Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
Jan Korbecki, Szymon Grochans, Izabela Gutowska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7619-7619
Open Access | Times Cited: 268

Showing 1-25 of 268 citing articles:

CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
Jan Korbecki, Klaudyna Kojder, Donata Simińska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8412-8412
Open Access | Times Cited: 323
Macrophage Polarity and Disease Control
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 144-144
Open Access | Times Cited: 199
CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory
Yujiro Kidani, Wataru Nogami, Yoshiaki Yasumizu, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 7
Open Access | Times Cited: 126
Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
Tetiana Hourani, James A. Holden, Wenyi Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 113
The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment
Yanghong Ni, Xiaoting Zhou, Jia Yang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 104
Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling
Barath Udayasuryan, Raffae N. Ahmad, Tam T. D. Nguyen, et al.
Science Signaling (2022) Vol. 15, Iss. 756
Open Access | Times Cited: 72
Insights Into the Role of Matrix Metalloproteinases in Cancer and its Various Therapeutic Aspects: A Review
Sabeena Mustafa, Sheeja Koran, Lamya AlOmair
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 71
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program
Ming Huang, Wen Dong, Ruihui Xie, et al.
Cancer Communications (2022) Vol. 42, Iss. 5, pp. 447-470
Open Access | Times Cited: 70
The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review
Toufik Abdul‐Rahman, Shankhaneel Ghosh, Sarah M. Badar, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 26
Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics
Tosin Akinsipe, Rania Mohamedelhassan, Ayuba Akinpelu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
A Programmable Peptidic Hydrogel Adjuvant for Personalized Immunotherapy in Resected Stage Tumors
Bihan Wu, Juan Liang, Xuejiao Yang, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 12, pp. 8585-8597
Closed Access | Times Cited: 15
Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillance
Zhikai Mai, Liwu Fu, Jiyan Su, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Tumor metastasis: Mechanistic insights and therapeutic interventions
Mengmeng Liu, Jing Yang, Bu-Shu Xu, et al.
MedComm (2021) Vol. 2, Iss. 4, pp. 587-617
Open Access | Times Cited: 76
Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?
Justine Cinier, Margaux Hubert, Laurie Besson, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1850-1850
Open Access | Times Cited: 74
Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context
Mannon Geindreau, Mélanie Bruchard, Frédérique Végran
Cancers (2022) Vol. 14, Iss. 10, pp. 2446-2446
Open Access | Times Cited: 63
Role of chemokines in the crosstalk between tumor and tumor-associated macrophages
Rui Qin, Weihong Ren, Guoqi Ya, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 5, pp. 1359-1373
Open Access | Times Cited: 63
Multifaceted role of chemokines in solid tumors: From biology to therapy
Sana Raza, Sangam Rajak, Archana Tewari, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 1105-1121
Open Access | Times Cited: 51
CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases
Sara Gómez-Melero, Javier Caballero‐Villarraso
Antibodies (2023) Vol. 12, Iss. 2, pp. 30-30
Open Access | Times Cited: 22
Targeting tumor-infiltrating tregs for improved antitumor responses
Diyuan Qin, Yugu Zhang, Pei Shu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14
The role of monocyte/macrophage chemokines in pathogenesis of osteoarthritis: A review
Hao Luo, Linfeng Li, Song Han, et al.
International Journal of Immunogenetics (2024) Vol. 51, Iss. 3, pp. 130-142
Open Access | Times Cited: 13
Regulatory T cells in immune checkpoint blockade antitumor therapy
An Zhang, Tao Fan, Yixiao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Strategies of Helicobacter pylori in evading host innate and adaptive immunity: insights and prospects for therapeutic targeting
Jiawei Fan, Jianshu Zhu, Hong Xu
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 11
Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade
Liang Zhao, Yizhen Pang, Yangfan Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Harnessing anti-inflammatory pathways and macrophage nano delivery to treat inflammatory and fibrotic disorders
Ahmad Zaid, Amiram Ariel
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115204-115204
Closed Access | Times Cited: 10
High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor
Fangming Wang, Gang Zhang, Tianli Xu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top